BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 1999
 |  BC Week In Review  |  Company News  |  Other News

Harvard Medical School other research news

Harvard researchers and colleagues published in Science that a peptide based on the calcineurin binding site for NFAT inhibited NFAT activation by calcineurin without blocking expression of...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >